PIII Competitors

PIII Stock  USD 0.48  0.04  9.09%   
P3 Health Partners competes with Sonida Senior, Acadia Healthcare, CryoCell International, Community Health, and Lifestance Health; as well as few others. The company conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing P3 Health competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of P3 Health to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out P3 Health Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of P3 Health competition on your existing holdings.
  
The current Return On Tangible Assets is estimated to decrease to -0.31. The current Return On Capital Employed is estimated to decrease to -0.31. As of now, P3 Health's Other Current Assets are increasing as compared to previous years. The P3 Health's current Debt To Assets is estimated to increase to 0.24, while Net Tangible Assets are forecasted to increase to (1.6 B).
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of P3 Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.020.486.67
Details
Intrinsic
Valuation
LowRealHigh
0.081.687.87
Details
Naive
Forecast
LowNextHigh
0.010.566.75
Details
4 Analysts
Consensus
LowTargetHigh
4.905.385.97
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as P3 Health. Your research has to be compared to or analyzed against P3 Health's peers to derive any actionable benefits. When done correctly, P3 Health's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in P3 Health Partners.

P3 Health Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between P3 Health and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of PIII and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of P3 Health Partners does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
BKDSNDA
AGLCCEL
USPHAGL
USPHBKD
BKDAGL
AGLSNDA
  
High negative correlations   
AGLLFST
LFSTCCEL
LFSTSNDA
BKDLFST
AGLCYH
CYHCCEL

Risk-Adjusted Indicators

There is a big difference between PIII Stock performing well and P3 Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze P3 Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
AIH  16.55  2.42  0.11  1.52  18.11 
 56.25 
 125.38 
SNDA  2.57 (0.26) 0.00 (0.11) 0.00 
 5.49 
 23.58 
ACHC  2.12 (0.37) 0.00 (0.69) 0.00 
 3.36 
 30.61 
CCEL  2.70 (0.23) 0.00 (0.96) 0.00 
 6.87 
 19.48 
CYH  2.42  0.41  0.16  0.34  2.44 
 6.72 
 17.66 
LFST  1.81  0.28  0.13  0.33  1.85 
 4.33 
 13.19 
AGL  3.85 (1.44) 0.00 (0.94) 0.00 
 8.70 
 22.71 
BKD  1.76 (0.44) 0.00 (0.25) 0.00 
 2.87 
 14.61 
INNV  2.39 (0.25) 0.00 (0.03) 0.00 
 5.56 
 12.94 
USPH  1.26 (0.30) 0.00 (0.23) 0.00 
 2.09 
 12.04 

Cross Equities Net Income Analysis

Compare P3 Health Partners and related stocks such as Aesthetic Medical Intl, Sonida Senior Living, and Acadia Healthcare Net Income Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
201020112012201320142015201620172018201920202021202220232024
SNDA3.7 MM(3.1 M)(16.5 M)(24.1 M)(14.3 M)(28 M)(44.2 M)(53.6 M)(36 M)(295.4 M)125.6 M(54.4 M)(21.1 M)(22.2 M)
ACHC6.2 M(34.9 M)20.4 M42.6 M83 M119.5 M6.1 M199.8 M(175.8 M)108.9 M143.2 M190.6 M273.1 M(21.7 M)(20.6 M)
CCEL600 K(6.3 M)27.4 K553.6 K8.1 M(1.3 M)2.3 M(854.8 K)2.3 M3.6 M2.1 M2.8 M(9.5 M)(10.9 M)(10.4 M)
CYH(16.8 M)201.9 M265.6 M141.2 M92 M158 M(1.7 B)(2.5 B)(788 M)(590 M)511 M368 M179 M(133 M)(139.7 M)
LFST5.7 M5.7 M5.7 M5.7 M5.7 M5.7 M5.7 M5.7 M5.7 M5.7 M(38.1 M)(307.2 M)(215.6 M)(186.3 M)(195.6 M)
AGL(114.5 M)(114.5 M)(114.5 M)(114.5 M)(114.5 M)(114.5 M)(114.5 M)(114.5 M)(114.5 M)(114.5 M)(63.2 M)(405.5 M)(106.9 M)(215 M)(225.8 M)
BKD3.4 M(68.2 M)(65.6 M)(3.6 M)(149 M)(457.5 M)(404.4 M)(571.4 M)(528.3 M)(268.5 M)82 M(99.4 M)(238.3 M)(189 M)(198.5 M)
INNV(4.8 M)(4.8 M)(4.8 M)(4.8 M)(4.8 M)(4.2 M)(13.7 M)(6.5 M)19.6 M26.3 M(44.7 M)(8 M)(40.7 M)(21.3 M)(20.3 M)
USPH(200 K)21 M17.9 M12.7 M19.8 M22.3 M20.6 M22.3 M10.1 M57.3 M52.5 M57.9 M43.4 M14.7 M15.6 M
EHAB24 M24 M24 M24 M24 M24 M24 M24 M24 M24 M75 M111.1 M62.5 M(80.5 M)(76.5 M)
ENSG3.6 M47.7 M40.6 M24 M36 M55.4 M50 M40.5 M92.4 M110.5 M170.5 M194.7 M224.7 M209.4 M219.9 M
SEM(27.9 M)107.8 M148.2 M114.4 M120.6 M130.7 M115.4 M177.2 M137.8 M201 M259 M402.2 M159 M243.5 M150.2 M
EHC(1.5 M)208.7 M185 M323.6 M222 M183.1 M247.6 M256.3 M292.3 M358.7 M284.2 M412.2 M271 M352 M369.6 M

P3 Health Partners and related stocks such as Aesthetic Medical Intl, Sonida Senior Living, and Acadia Healthcare Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in P3 Health Partners financial statement analysis. It represents the amount of money remaining after all of P3 Health Partners operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

P3 Health Competitive Analysis

The better you understand P3 Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, P3 Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across P3 Health's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
PIII AIH SNDA ACHC CCEL CYH LFST AGL BKD INNV
 9.09 
 0.48 
PIII
 5.88 
 0.32 
Aesthetic
 1.46 
 25.63 
Sonida
 1.74 
 50.76 
Acadia
 0.32 
 6.20 
CryoCell
 1.09 
 5.55 
Community
 3.85 
 6.99 
Lifestance
 4.61 
 2.69 
Agilon
 0.32 
 6.16 
Brookdale
 3.05 
 5.73 
InnovAge
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Five Year Return
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Z Score
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Last Dividend Paid
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

P3 Health Competition Performance Charts

Five steps to successful analysis of P3 Health Competition

P3 Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by P3 Health Partners in relation to its competition. P3 Health's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of P3 Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact P3 Health's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to P3 Health Partners, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your P3 Health position

In addition to having P3 Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Communication Thematic Idea Now

Communication
Communication Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Communication theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Communication Theme or any other thematic opportunities.
View All  Next Launch
When determining whether P3 Health Partners is a strong investment it is important to analyze P3 Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact P3 Health's future performance. For an informed investment choice regarding PIII Stock, refer to the following important reports:
Check out P3 Health Correlation with its peers.
You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of P3 Health. If investors know PIII will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about P3 Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.64)
Revenue Per Share
11.552
Quarterly Revenue Growth
0.152
Return On Assets
(0.12)
Return On Equity
(0.41)
The market value of P3 Health Partners is measured differently than its book value, which is the value of PIII that is recorded on the company's balance sheet. Investors also form their own opinion of P3 Health's value that differs from its market value or its book value, called intrinsic value, which is P3 Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because P3 Health's market value can be influenced by many factors that don't directly affect P3 Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between P3 Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if P3 Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, P3 Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.